Active — Not RecruitingNot Applicable

RT for Cervical Adenocarcinoma/adenosquamous Carcinoma

China400 participantsStarted 2014-06-01

Plain-language summary

The purpose of this study was to retrospectively analyze patients with cervical adenocarcinoma/adenosquamous carcinoma who had been admitted to our hospital. Approximately 500 cases of cervical adenocarcinoma were planned to be included, summarize the disease characteristics, treatment regimens, and recurrence patterns of the patients, and analyze the association between treatment regimens and recurrence patterns and prognosis.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients who have received pelvic radiotherapy before;
✕. Patients whose target tumors have been treated before (chemotherapy, immunotherapy, surgical treatment, etc.);
✕. Allergy to iodine contrast agent;
✕. Participating in other clinical studies that may affect the results of this study (determined by the principal investigator);

What they're measuring

Local control rate

Timeframe: local control rates at 2 years or 3 years after the initial treatment

Trial details

NCT IDNCT06741046

SponsorPeking Union Medical College Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-01

View on ClinicalTrials.gov More Uterine Neoplasms trials